Leukemia Fusion Genes (Q55)Screening Kit
Product TypeAssay Kit
TechnologyqPCR
Regulatory StatusRUO
Sample TypesWhole Blood

Key takeaways
Leukemia Fusion Genes (Q55)Screening Kit is a product in the Molecular Assays category, manufactured by Zeesan Biotech (致善生物). Listed regulatory status: RUO (as reported by the manufacturer).
- Platform: qPCR
- Sample types: whole blood
Classification
- Category
- Molecular Assays
- Product Type
- Assay Kit
- Technology
- qPCR
Workflow
- Sample Types
- Whole Blood
Regulatory Status
RUO
Reported from manufacturer sources and not independently verified.
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
The Leukemia Fusion Genes (Q55) Screening Kit is a qualitative multiplex assay developed to detect 55 leukemia-associated genes.
Leukemia Fusion Genes (Q55)Screening Kit is a multiplex RT-qPCR based assay for detection of the 55 leukemia-associated genes transcripts including EVI1, HOX11, HOX11L2 and 52 fusion genes in total RNA from human bone marrow or peripheral whole blood samples.
The kit utilizes an RT-qPCR procedure to detect RNA transcripts of fusion genes extracted from human bone marrow or peripheral whole blood samples.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-17
2026-10-31
availability varies
